Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD

Inclusion Criteria: * Patient must be between the ages of 4 and 11 years at the time of entry into the study. * Patients must meet diagnostic criteria for FASD * Patient must meet DSM-IV criteria for ADHD, any subtype and must have an ADHDRS-IV score of \> or = to 90%ile for age and gender for either subtest or total score if greater than 5 years of age. * Patients who enter the study at visit 1 taking stimulant medication must be medication-free for at least 24 hours before visit 2. * History and physical exam must reveal no clinically significant abnormalities that would preclude safe participation in the study. * Patients must be able to swallow capsules. * Patients must be of a sufficient developmental level (\~3 yrs) to participate in the study. * Patients and parents must be able to communicate effectively with the investigator and coordinator and be judged reliable to keep appointments and participate in data collection. * Teacher must agree to cooperate with the study. Children less than 6 years old must have completed a course of PCIT and still meet DSM-IV criteria for ADHD. Exclusion Criteria: * Have received an in investigational medication in the past 30 days. * Are currently on a medication treatment that is effective (ADHDRS-IV score within 1 SD of average) and well tolerated. * Have significant current medical conditions that could be exacerbated or compromised by atomoxetine. * Have used MAOIs within one month prior to visit 2. * Patients with hypertension.…